PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Hospital Careggi, Florence, Italy.\', \'Department of Neurofarba, University of Florence, Florence, Italy.\', \'Neurology Department, Klinikum rechts der Isar TU München, Münich, Germany/Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.\', \'Departments of Neurology and Biomedicine, University Hospital of Basel, Basel, Switzerland.\', \'Department of Neurology, ICM, Hôpital Pitié Salpêtrière, Paris, France.\', \'Department of Neurology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.\', \'Department of the Neurology/Neuroimmunology and Research Institute Barcelona, Multiple Sclerosis Centre of Catalonia (Cemcat), Barcelona, Spain.\', \'Department of Neurofarba, University of Florence, Florence, Italy/IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/13524585211005339
?:hasPublicationType
?:journal
  • Multiple sclerosis (Houndmills, Basingstoke, England)
is ?:pmid of
?:pmid
?:pmid
  • 33764197
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all